Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Dunn

Showing results (361-370 of 392) with videos related to

Pageof 40
Sort By:
Antiviral Therapy|July 21, 2012
Lopinavir/ritonavir monotherapy after 24 weeks of second-line antiretroviral therapy in Africa: a randomized controlled trial (SARA)Charles F Gilks, A Sarah Walker, David T Dunn, et al.
HIV Medicine|January 18, 2008
Patterns and predictors of the use of different antiretroviral drug regimens at treatment initiation in the UKP J Easterbrook, A N Phillips, T Hill, et al.
Cancer Discovery|September 6, 2018
<i>Crebbp</i> Loss Drives Small Cell Lung Cancer and Increases Sensitivity to HDAC InhibitionDeshui Jia, Arnaud Augert, Dong-Wook Kim, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|August 6, 2010
Evolution of drug resistance during 48 weeks of zidovudine/lamivudine/tenofovir in the absence of real-time viral load monitoringFred Lyagoba, David T Dunn, Deenan Pillay, et al.
BMC Infectious Diseases|October 25, 2018
Protocol, rationale and design of SELPHI: a randomised controlled trial assessing whether offering free HIV self-testing kits via the internet increases the rate of HIV diagnosisMichelle M Gabriel, David T Dunn, Andrew Speakman, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 12, 2018
Determining the Origins of Human Immunodeficiency Virus Type 1 Drug-resistant Minority Variants in People Who Are Recently Infected Using Phylogenetic ReconstructionJean L Mbisa, Peter Kirwan, Anna Tostevin, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|August 5, 2011
Development and evaluation of a genomic signature for the prediction and mechanistic assessment of nongenotoxic hepatocarcinogens in the ratMark R Fielden, Alex Adai, Robert T Dunn, et al.
BMC Infectious Diseases|August 9, 2019
Pilot phase of an internet-based RCT of HIVST targeting MSM and transgender people in England and Wales: advertising strategies and acceptability of the interventionT Charles Witzel, Michelle M Gabriel, Leanne McCabe, et al.
Plos One|January 5, 2011
A novel statistical algorithm for gene expression analysis helps differentiate pregnane X receptor-dependent and independent mechanisms of toxicityM Ann Mongan, Robert T Dunn, Steven Vonderfecht, et al.
Translational Psychiatry|September 20, 2022
From bench to bedside: The mGluR5 system in people with and without Autism Spectrum Disorder and animal model systemsCornelia Carey, Nisha Singh, Joel T Dunn, et al.
Pageof 40

Showing results (361-370 of 392) with videos related to

Sort By:
Pageof 40
Antiviral Therapy|July 21, 2012
Lopinavir/ritonavir monotherapy after 24 weeks of second-line antiretroviral therapy in Africa: a randomized controlled trial (SARA)Charles F Gilks, A Sarah Walker, David T Dunn, et al.
HIV Medicine|January 18, 2008
Patterns and predictors of the use of different antiretroviral drug regimens at treatment initiation in the UKP J Easterbrook, A N Phillips, T Hill, et al.
Cancer Discovery|September 6, 2018
<i>Crebbp</i> Loss Drives Small Cell Lung Cancer and Increases Sensitivity to HDAC InhibitionDeshui Jia, Arnaud Augert, Dong-Wook Kim, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|August 6, 2010
Evolution of drug resistance during 48 weeks of zidovudine/lamivudine/tenofovir in the absence of real-time viral load monitoringFred Lyagoba, David T Dunn, Deenan Pillay, et al.
BMC Infectious Diseases|October 25, 2018
Protocol, rationale and design of SELPHI: a randomised controlled trial assessing whether offering free HIV self-testing kits via the internet increases the rate of HIV diagnosisMichelle M Gabriel, David T Dunn, Andrew Speakman, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 12, 2018
Determining the Origins of Human Immunodeficiency Virus Type 1 Drug-resistant Minority Variants in People Who Are Recently Infected Using Phylogenetic ReconstructionJean L Mbisa, Peter Kirwan, Anna Tostevin, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|August 5, 2011
Development and evaluation of a genomic signature for the prediction and mechanistic assessment of nongenotoxic hepatocarcinogens in the ratMark R Fielden, Alex Adai, Robert T Dunn, et al.
BMC Infectious Diseases|August 9, 2019
Pilot phase of an internet-based RCT of HIVST targeting MSM and transgender people in England and Wales: advertising strategies and acceptability of the interventionT Charles Witzel, Michelle M Gabriel, Leanne McCabe, et al.
Plos One|January 5, 2011
A novel statistical algorithm for gene expression analysis helps differentiate pregnane X receptor-dependent and independent mechanisms of toxicityM Ann Mongan, Robert T Dunn, Steven Vonderfecht, et al.
Translational Psychiatry|September 20, 2022
From bench to bedside: The mGluR5 system in people with and without Autism Spectrum Disorder and animal model systemsCornelia Carey, Nisha Singh, Joel T Dunn, et al.
Pageof 40